A new, daily oral tablet that combines two current HIV treatment medications, bictegravir and lenacapavir (BIC/LEN), could effectively replace more complicated HIV treatment regimens used by people living with HIV who are long-term survivors,…
Continue Reading
News Source: medicalxpress.com
Leave a Reply